Features Regulatory roundup: BMS’s T lymphocyte immunotherapy tripped by lung cancer trial termination Features Regulatory roundup: Ology, MaxCyte make moves in women’s cancer with divergent approval chances
Features Akebia and GSK will grapple with heightened scrutiny of HIF PHIs after roxadustat concerns Manasi Vaidya
Features Regulatory roundup: Servier, Pfizer and Debiopharm gather gains with oncology trial updates; Karyopharm poses a loss Manasi Vaidya
Features Race to develop mRNA flu vaccines will contend with a longer review than Covid-19 Manasi Vaidya
Features BioMarin’s growth-accelerating drug for dwarfism will face scrutiny from European payers William Newton
Features Medicare’s National Coverage Determination could boost chances of limited Aduhelm coverage despite backlash William Newton
Comment Setback for Kyowa’s Nouryant in European Parkinson’s disease market – register for free webinar GlobalData Healthcare
Features IoT must become the Internet of Secure Things for widescale acceptance in the 5G era Giacomo Lee